ArriVent BioPharma, Inc. - Common Stock
ArriVent BioPharma, Inc. - Common Stock
Share · US04272N1028 · AVBP (XNAS)
Overview Financial Indicators
23,27 USD
-1,52 % -0,36 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 20:00

Current Prices from ArriVent BioPharma, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AVBP
USD
13.06.2025 20:00
23,27 USD
23,63 USD
-1,52 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -1,06 % 24,11 % 10,81 % -12,98 % 24,44 % 16,35 %

Company Profile for ArriVent BioPharma, Inc. - Common Stock Share

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

Company Data

Name ArriVent BioPharma, Inc. - Common Stock
Company ArriVent BioPharma, Inc. Common Stock
Symbol AVBP
Website https://www.arrivent.com
Primary Exchange XNAS NASDAQ
ISIN US04272N1028
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Zhengbin Yao Ph.D.
Market Capitalization 614 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 18 Campus Boulevard, 19073 Newtown Square
IPO Date 2024-01-26

Ticker Symbols

Name Symbol
NASDAQ AVBP

More Shares

Investors who ArriVent BioPharma, Inc. - Common Stock hold also have the following shares in their portfolio:
GRIECHENLAND 17-33
GRIECHENLAND 17-33 Bond
LB.HESS.-THR.ZI.DI.02A/15
LB.HESS.-THR.ZI.DI.02A/15 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025